Real‐World Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First‐Line Tumor Necrosis Factor Inhibitor Therapy in the United States

Ähnliche Einträge

• Tumor Necrosis Factor Inhibitor Therapy Increases Absolute Lymphocyte Count and Is Associated With Lower Mortality in Patients With Psoriatic Arthritis
  von: Lenche Kostadinova, et al.
  Veröffentlicht: (2025)
• Characterization of Second‐Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry
  von: Joshua F. Baker, et al.
  Veröffentlicht: (2025)
• Difficult‐to‐Treat Rheumatoid Arthritis With Concomitant Yao Syndrome With Response to Dual‐Inhibitor Therapy
  von: Nawar Aljundi, et al.
  Veröffentlicht: (2026)
• Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid Arthritis
  von: Georgios K. Vasileiadis, et al.
  Veröffentlicht: (2024)
• Clinical Course of Interstitial Lung Disease in Patients With Rheumatoid Arthritis
  von: Eric L. Matteson, et al.
  Veröffentlicht: (2024)